SPRO: Spero Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 34.66
Enterprise Value ($M) -18.23
Book Value ($M) 46.12
Book Value / Share 0.83
Price / Book 0.75
NCAV ($M) -11.53
NCAV / Share -0.21
Price / NCAV -3.01

Profitability (mra)
Return on Invested Capital (ROIC) -1.36
Return on Assets (ROA) -0.41
Return on Equity (ROE) -0.71

Liquidity (mrq)
Quick Ratio 1.08
Current Ratio 1.08

Balance Sheet (mrq) ($M)
Current Assets 52.89
Assets 110.54
Liabilities 64.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 47.98
Operating Income -72.48
Net Income -68.57
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -23.44
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-28 13D/A Glaxosmithkline Plc 16.40 0.00
11-14 13G/A Anson Funds Management LP 6.90 -12.73

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 8,525 57,557 14.81
2025-05-08 40,375 169,993 23.75
2025-05-07 15,794 53,452 29.55
2025-05-06 22,602 84,221 26.84
2025-05-05 18,432 106,773 17.26

(click for more detail)

Similar Companies
SLDB – Solid Biosciences Inc. SLRN – Acelyrin, Inc.
SNDX – Syndax Pharmaceuticals, Inc. SRPT – Sarepta Therapeutics, Inc.
SRRK – Scholar Rock Holding Corporation


Financial data and stock pages provided by
Fintel.io